Willkommen, schön sind Sie da!
Logo Ex Libris

The Tumor Microenvironment

  • Kartonierter Einband
  • 788 Seiten
(0) Erste Bewertung abgeben
Bewertungen
(0)
(0)
(0)
(0)
(0)
Alle Bewertungen ansehen
This book explores the many biological and physical aspects of the tumor microenvironment. It represents a superb compilation of t... Weiterlesen
20%
346.00 CHF 276.80
Print on Demand - Auslieferung erfolgt in der Regel innert 4 bis 6 Wochen.
Bestellung & Lieferung in eine Filiale möglich

Beschreibung

This book explores the many biological and physical aspects of the tumor microenvironment. It represents a superb compilation of the latest thoughts and data on this topic, and the in-depth chapters are written by known professionals in the field. This book will explore the many biological and physical aspects of the tumor microenvironment. The book will include chapters on the various cells that influence tumor growth and function as well as the cell-associated and soluble proteins that can promote invasion and metastasis. Several chapters will describe endothelial cells and pericytes that form tumor vasculature. Insights on the role of progenitor and stem cells will be included. The contribution of the supporting stroma will be addressed in addition to cell-cell signaling and cell-matrix interactions. Additional chapters will describe the influence of infiltrating cells of the immune system on tumor growth.

The fact that tumors are composed of both tumor cells and host cells has long been known. These tumor-associated cells include vascular endothelial cells and pe- cytes, as well as inflammatory cells such as neutrophils, monocytes, macrophages, mast cells and eosinophils, and lymphocytes. The tumor cells also interact with stromal cells and with elements of the tissue extracellular matrix. What has been less appreciated is the role that these cells could have in modulating the growth, invasion, and metastasis of the tumor. Early on, the elements of what we now call the tumor microenvironment were considered to be more or less innocent bysta- ers to the role of the tumor cells as they grew and invaded local sites. Today, there is an increased understanding of the critical role of the tumor microenvironment as dramatically influencing the course of tumor development and dissemination. This volume represents a superb compilation of the latest thoughts and data regarding the role of each essential component of the tumor microenvironment in cancer development and progression. Perhaps, the earliest recognition of the role of nonmalignant cells as cancer re- lators was the recognition that lymphocytes can participate in what was termed immune surveillance in the 1960s. Our understanding of tumor immunity has improved markedly since then, and there are now successful clinical studies sh- ing the potential use of immune-based therapies in cancer treatment.

Explains role of the tumor microenvironment as dramatically influencing the course of tumor development and dissemination

Represents a superb compilation of the latest thoughts and data regarding the role of each essential component of the tumor microenvironment

In-depth chapters written by known professionals in the field



Autorentext
Rebecca Bagley is a senior scientist at Genzyme Corporation and has worked in the biotechnology industry for 20 years with degrees in biology from Wellesley College and Harvard University. Her expertise in drug development spans a wide range of approaches including immunotherapies, gene and protein therapies, and small molecule delivery with publications in journals such as Molecular Cancer Therapeutics, Cancer Research, and Microvascular Research . Her current research focuses on stem cells, tumor vasculature, and target validation.

Klappentext
The field of cancer biology and developmental therapeutics is continually evolving as new methodologies are developed and new targets are discovered. Although multiple therapeutics directly target the malignant cells these drugs rarely prevent recurrence of disease or the progression of metastasis. The complex biology of tumors presents challenges in designing treatments that will eliminate the malignant cells as well as the supporting network of vasculature and stroma that allows for the comparison of tumors to developing organs in embryos. In addition to blood vessels and malignant cells, tumors consist of fibroblasts, immune and inflammatory cells, and a myriad of proteins that comprise the extracellular matrix. Effective eradication of malignant disease requires therapeutic strategies that factor in targeting the tumor microenvironment. In the past decade, a new class of anticancer drugs has emerged that interferes with tumor angiogenesis; however the clinical benefit from treatment with the first generation antiangiogenic agents added to the standard of care is often modest. Thus, there remains a critical need to understand the tumor microenvironment and to develop anti-cancer therapies that address this aspect of malignant disease. The first edition of The Tumor Microenvironment is intended to give a current perspective on the role of the tumor microenvironment in malignant progression and detail strategies for novel therapies directed towards the cellular matrix. This book explores the many biological and physiological aspects of the tumor as a tissue and includes chapters on the variety of cells that influence tumor growth and spread as well as the cell-associated and soluble proteins that can promote invasion and metastasis. Several chapters describe endothelial cells and pericytes that form tumor vasculature. Insights into the role of progenitor and stem cells are included. The contribution of the supporting stroma is addressed in addition to cell-cell signaling and cell-matrix interactions. Additional chapters describe the influence of infiltrating cells of the immune system on tumor growth. The Tumor Microenvironment is the definitive text detailing cutting edge research by experts in the field and will be a valued resource in the study of this important area of cancer biology for many years to come.

Inhalt
Preface Bruce Zetter, PhD Table of Contents: PHYSIOLOGICAL PARAMETERS 1. Combination Strategies Targeting Hypoxia Inducible Factor 1 (HIF-1) for Cancer Therapy Annamaria Rapisarda, PhD and Giovanni Melillo, MD 2. New Insights into Regulation of Tumor pH by Carbonic Anhydrases Pawel Swietach,DPhil, Adrian L. Harris, DPhil/MBChB, and Richard D. Vaughan-Jones1,PhD 3. Hypoxia, Gene Expression and Metastasis Olga V. Razorenova, PhD and Amato J. Giaccia, PhD 4. Molecular Mechanisms Regulating Expression and Function of Cancer-Associated Carbonic Anhydrase IX Jaromir Pastorek, PhD and Silvia Pastorekova, PhD 5. Glycolytic Pathway as a Target for Tumor Inhibition Weiqin Lu, PhD and Peng Huang, MD/PhD CELLULAR COMPONENTS I. MALIGNANT CELLS 6. Aberrant DNA Methylation in Cancer Cells Toshikazu Ushijima, MD/PhD 7. DNA Repair and Redox Signaling Mark R. Kelley, PhD, Millie M Georgiadis, PhD, and Melissa L. Fishel, PhD 8. Cancer Stem Cells and Microenvironment Mario Federico, MD and Antonio Giordano, MD/PhD 9. Epithelial-Mesenchymal Transition in Development and Diseases Yadi Wu,PhD and Binhua P. Zhou, MD/PhD 10. Invasion and Metastasis Douglas M. Noonan, PhD, Giuseppina Pennesi, MD, and Adriana Albini, PhD 11. Dormancy of Disseminated Tumor Cells: Reciprocal Crosstalk with the Microenvironment Paloma Bragado, PhD, Aparna C. Ranganathan, PhD, and Julio Aguirre-Ghiso, PhD II. VASCULATURE AND STROMA 12. Impact of Endothelial Progenitor Cells on Tumor Angiogenesis and Outcome of Antiangiogenic Therapy: New Perspectives on an Ongoing Controversy Robert S. Kerbel1, PhD, Francesco Bertolini, MD/PhD, and Yuval Shaked, PhD 13. Bone Marrow Derived Mesenchymal Stem/Stromal Cells and Tumor Growth Pravin J. Mishra, MS and Debabrata Banerjee, PhD 14. Integrin Signaling in Lymphangiogenesis Barbara Garmy-Susini, PhD 15. Role of Pericytes in Resistance to Anti-Angiogenic Therapy Koji Matsuo, MD, Chunhua Lu1, MD/PhD Mian M K. Shazad, MS/MD, Robert L. Coleman,MD, and Anil K. Sood, MD 16. Tumour-Promoting Stromal Fibroblasts in Human Carcinomas Urszula M. Polanska, Msc/PhD, Kieran T. Mellody, BSc./MPhil., and Akira Orimo, MD/PhD* III. IMMUNE-MEDIATED CELLS 17. Mast cells and tumor microenvironment Theoharis C. Theoharides, MS/MD/PhD, Konstantinos-Dionysios Alysandratos, MD, Asimenia Angelidou, MD, and Bodi Zhang, MD/MPH 18. Macrophages in the Tumor Microenvironment Monica Escorcio-Correia, PhD and Thorsten Hagemann, MD/PhD 19. The Prognostic Significance of Tumor-Infiltrating Lymphocytes Ping Yu, MD/PhD and Yang-Xin Fu, MD/PhD 20. The Pro-Inflammatory Milieu and Pre-Malignant Epithelial Initiation Adam Yagui-Beltran, MD, Lisa M. Coussens, PhD, Qizi Tang, PhD, and David Jablons, MD 21. Natural Killer Cells for Adoptive Immunotherapy Jonathan E. Benjamin, MD/PhD and Sally Arai, MD EXTRACELLULAR MATRIX 22. Fibronectin Andreas Menrad, PhD 23. Collagen in Cancer Janelle L. Lauer, PhD and Gregg B. Fields, PhD 24. Integrins and Cancer Laurie G. Hudson,PhD and M. Sharon Stack, PhD 25. Matrix Metalloproteinases and Cancer Cell Invasion/Metastasis Stanley Zucker, MD and Jian Cao, PhD 26. Tetraspanins and Cancer Metastasis Margot Zoller, PhD SECRETED PROTEINS 27. Chemokines and Metastasis Kalyan C. Nannuru, PhD, Seema Singh, PhD, and Rakesh K. Singh, PhD 28. Transforming Growth Factor-? in Lung Cancer, Carcinogenesis and Metastasis Sonia B. Jakowlew, PhD 29. Cooperative Interactions Between Integrins and Growth Factors in Pathological Angiogenesis Jennifer M. Roth, MS, Eric Tweedie, BS, and Peter C. Brooks, PhD 30. The Extracellular Matrix and the Growth and Survival of Tumors Yves DeClerck, MD 31. Secreted Growth Factors as Therapeutic Targets Beverly A. Teicher, PhD 32. Adrenomedullin in Tumor Development Rebecca G. Bagley, MS

Produktinformationen

Titel: The Tumor Microenvironment
Editor:
EAN: 9781461426608
ISBN: 146142660X
Format: Kartonierter Einband
Herausgeber: Springer New York
Genre: Medizin
Anzahl Seiten: 788
Gewicht: 1171g
Größe: H235mm x B155mm x T41mm
Jahr: 2012
Auflage: 2010